Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome

Naoto T. Ueno, Athanasios Anagnostopoulos, Gabriela Rondón, Richard E. Champlin, N. Mikhailova, O. S. Pankratova, L. S. Zoubarovskaya, E. V. Semenova, B. V. Afanasyev, Susan O'Brien, Michael Andreeff, Andrey Y. Zaritskey

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

In this report, we describe two patients with idiopathic hypereosinophilic syndrome (HES) who received a non-myeloablative allogeneic transplantation following a reduced-intensity preparative regimen of melphalan and fludarabine. In both cases, complete donor chimaerism and remission were achieved, and have lasted for more than 10 months. This report provides proof of principle for the feasibility of non-myeloablative transplantation for patients with idiopathic HES, who can show co-morbidity due to eosinophilic infiltration of their organs.

Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
JournalBritish Journal of Haematology
Volume119
Issue number1
DOIs
StatePublished - 2002

Keywords

  • Blood and marrow transplantation
  • Eosinophils
  • Idiopathic hypereosinophilic syndrome

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome'. Together they form a unique fingerprint.

Cite this